The slideshow accompanying Dr. Scott Singleton's presentation about the PharmD-PhD program at the UNC Eshelman School of Pharmacy during the information sessions for prospective PharmD applicants on August 12, 2009. To see the video of the session, visit http://bit.ly/q3Vle
Slides I used in a Research Methodology seminar I gave in 2010 for the Interactive Art PhD at School of Arts of the Portuguese Catholic University, Porto, Portugal (http://artes.ucp.pt)
June 22, 2009, Aspiring Summer Scientist Internship Program presentation. NPA Core Competencies for high school and undergraduate biomedical researchers.
A presentation to high school students at Chula Vista High School, San Diego as part of nifty-fifty where scientists go into the high schools and try and excite students to a career in science. These slides describe my own particular career path.
Slides I used in a Research Methodology seminar I gave in 2010 for the Interactive Art PhD at School of Arts of the Portuguese Catholic University, Porto, Portugal (http://artes.ucp.pt)
June 22, 2009, Aspiring Summer Scientist Internship Program presentation. NPA Core Competencies for high school and undergraduate biomedical researchers.
A presentation to high school students at Chula Vista High School, San Diego as part of nifty-fifty where scientists go into the high schools and try and excite students to a career in science. These slides describe my own particular career path.
Pre-discovery
Understand the disease
Target Identification
Choose a molecule to target with a drug
Target Validation
Test the target and confirm its role in the disease
Drug Discovery
Find a promising molecule (a “lead compound”)
that could become a drug
At the Exploratory Clinical Trials event on 8-9 December 2009 in Brussels, Belgium you’ll have the opportunity to question the MHRA in person on the updated ICH M3 guidelines and find out how you can maximise your chance of easily gaining approval for your trials.
Exploratory Clinical Trials conference, being held Tuesday 1 and Wednesday 2 December 2009 in Brussels, Belgium, will bring experts from the pharmaceutical and biotech industry together to discuss these issues and the latest developments within the field of exploratory clinical trials. Through a series of presentation, case studies and interactive discussions, participants will gain practical insight into key issues such as gaining regulatory approval, implementing and running exploratory studies successfully and efficiently, the role of biomarkers, utilising effective modelling and simulations tools as well as the mitigation of safety risks.
di Stefano Govoni. Slide per l'intervento nell'incontro "Il nuovo ruolo dei pazienti nella medicina di precisione" (Milano, Fondazione Giannino Bassetti, 5 aprile 2018), secondo appuntamento del ciclo "La medicina di precisione: opportunità terapeutiche e responsabilità pubblica", prima espressione della collaborazione tra Università di Pavia e Fondazione Giannino Bassetti.
Kits for modulation of anti-rejection therapies and early detection of neurod...Toscana Open Research
The invention consists of a nanofunctionalized device that enables the quantitative determination of a specific biomarker, the FKBP12 protein, involved in many diseases.
Pre-discovery
Understand the disease
Target Identification
Choose a molecule to target with a drug
Target Validation
Test the target and confirm its role in the disease
Drug Discovery
Find a promising molecule (a “lead compound”)
that could become a drug
At the Exploratory Clinical Trials event on 8-9 December 2009 in Brussels, Belgium you’ll have the opportunity to question the MHRA in person on the updated ICH M3 guidelines and find out how you can maximise your chance of easily gaining approval for your trials.
Exploratory Clinical Trials conference, being held Tuesday 1 and Wednesday 2 December 2009 in Brussels, Belgium, will bring experts from the pharmaceutical and biotech industry together to discuss these issues and the latest developments within the field of exploratory clinical trials. Through a series of presentation, case studies and interactive discussions, participants will gain practical insight into key issues such as gaining regulatory approval, implementing and running exploratory studies successfully and efficiently, the role of biomarkers, utilising effective modelling and simulations tools as well as the mitigation of safety risks.
di Stefano Govoni. Slide per l'intervento nell'incontro "Il nuovo ruolo dei pazienti nella medicina di precisione" (Milano, Fondazione Giannino Bassetti, 5 aprile 2018), secondo appuntamento del ciclo "La medicina di precisione: opportunità terapeutiche e responsabilità pubblica", prima espressione della collaborazione tra Università di Pavia e Fondazione Giannino Bassetti.
Kits for modulation of anti-rejection therapies and early detection of neurod...Toscana Open Research
The invention consists of a nanofunctionalized device that enables the quantitative determination of a specific biomarker, the FKBP12 protein, involved in many diseases.
This slideshow provides a glimpse of the UNC Eshelman School of Pharmacy, UNC-Chapel Hill, and the state of North Carolina for those interested in attending the Eighth Meeting of the Globalization of Pharmaceutics Education Network, to be held at the School on November 10-12, 2010.
Embracing GenAI - A Strategic ImperativePeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
Palestine last event orientationfvgnh .pptxRaedMohamed3
An EFL lesson about the current events in Palestine. It is intended to be for intermediate students who wish to increase their listening skills through a short lesson in power point.
Francesca Gottschalk - How can education support child empowerment.pptxEduSkills OECD
Francesca Gottschalk from the OECD’s Centre for Educational Research and Innovation presents at the Ask an Expert Webinar: How can education support child empowerment?
Read| The latest issue of The Challenger is here! We are thrilled to announce that our school paper has qualified for the NATIONAL SCHOOLS PRESS CONFERENCE (NSPC) 2024. Thank you for your unwavering support and trust. Dive into the stories that made us stand out!
Unit 8 - Information and Communication Technology (Paper I).pdfThiyagu K
This slides describes the basic concepts of ICT, basics of Email, Emerging Technology and Digital Initiatives in Education. This presentations aligns with the UGC Paper I syllabus.
Acetabularia Information For Class 9 .docxvaibhavrinwa19
Acetabularia acetabulum is a single-celled green alga that in its vegetative state is morphologically differentiated into a basal rhizoid and an axially elongated stalk, which bears whorls of branching hairs. The single diploid nucleus resides in the rhizoid.
Instructions for Submissions thorugh G- Classroom.pptxJheel Barad
This presentation provides a briefing on how to upload submissions and documents in Google Classroom. It was prepared as part of an orientation for new Sainik School in-service teacher trainees. As a training officer, my goal is to ensure that you are comfortable and proficient with this essential tool for managing assignments and fostering student engagement.
1. PharmD Information Session
Pharmaceutical Sciences
PharmD-PhD Career Track
Scott F. Singleton, PhD
Director of Graduate Studies
Thursday, August 13, 2009
2. what is a PhD?
Doctor of Philosophy
from the Latin Philosophiæ Doctor, meaning
"teacher of philosophy"
the most advanced academic degree
awarded by universities in a wide array of
disciplines in the sciences and humanities
a requirement for a career as a university
professor or researcher in many fields
a research degree
Thursday, August 13, 2009
3. why a PhD?
always learning
work one-on-one with a mentor
creating new knowledge (information):
transition from a consumer of knowledge to a
producer of knowledge
transition from being taught to self-teaching
transition from problem-solving to teaching
PhD’s direct the investigations
Thursday, August 13, 2009
4. why Pharmaceutical Sciences?
pharmacists/pharmaceutical scientists care about
drugs (more so than MD’s)
what should be targeted to address an unmet need?
how to make new drugs?
how to make drugs or drug candidates better (making academic
concepts viable)?
how to better use medication to effect better patient outcomes
how to effect better patient outcomes through information or
policy
discoveries in “the lab” lead to new routine
standards of practice
Thursday, August 13, 2009
5. fast facts
each of our PhD students receives full financial support,
including a competitive stipend (as either a Research or Teaching
Assistantship), paid tuition, and health insurance
our students complete the PhD program in approximately 5 years
our graduates find desirable positions in academia, research
institutes, federal agencies, patent law, and pharmaceutical &
biotechnology industries
our location in UNC’s health sciences complex in the world-
renowned Research Triangle provides a great atmosphere of
collaboration with other UNC scientists as well as those at Duke,
NC State University, and numerous biotechnology and
pharmaceutical companies in Research Triangle Park
Thursday, August 13, 2009
7. 103 PhD students in 4 tracks
DPET
18
MOPH DPOP
32 12
MCNP
41
Thursday, August 13, 2009
8. a unique perspective
STAGE 1 STAGE 2 STAGE 3 STAGE 4
Discovery Optimization Assessment Outcomes
Pharmacotherapy Pharmaceutical
Medicinal Chemistry
Molecular & Outcomes
&
Pharmaceutics Experimental &
Natural Products
Therapeutics Policy
TARGET DISCOVERY DRUG DELIVERY CLINICAL ASSESSMENT ECONOMIC &
TARGET VALIDATION DRUG SAFETY & EVALUATION OF HEALTH OUTCOMES OF
DRUG DESIGN DRUG EFFICACY DRUG CANDIDATES DRUG THERAPIES
The School's PhD program has four
multidisciplinary concentrations that reflect our
collaborative approach to science.
Thursday, August 13, 2009
9. sequential PharmD-PhD program
two complete curricula & degrees
take PhD courses in place of PharmD
electives
get involved in research during PharmD
can “save” 12 – 18 months
Thursday, August 13, 2009
10. how do I know if I should consider it?
chemistry clinical drug trials
biology
computer science epidemiology
drug discovery
economics drug delivery
pharmacology
sociology psychology
engineering
Thursday, August 13, 2009
11. how do I know what to study?
find some papers
begin reading them at 10 pm
if it didn’t put you to sleep, then you
should join a lab doing that kind of
research
Thursday, August 13, 2009
12. how do I find out more?
Scott Singleton
sfs@unc.edu
Director of Graduate Studies
Craig Lee
craig_lee@unc.edu
Mike Jarsfter DPET - Dir. Grad. Admiss.
jarstfer@email.unc.edu
MCNP - Dir. Grad. Admiss.
Rick Hansen
rhansen@unc.edu
DPOP - Dir. Grad. Studies
Mike Jay
mjay@unc.edu
MOPH - Dir. Grad. Admiss.
Amber Allen
amber_allen@unc.edu
Student Services Manager
Thursday, August 13, 2009